Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast. 1993

M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
Servizio di Anatomia Patologica, Ospedali Galliera di Genova.

By means of an AgNOR technique, the authors have carried out a retrospective study on proliferative activity in 170 cases of infiltrating ductal breast carcinoma (so-called carcinoma NOS). The follow-up period was 138 months. A statistically significant correlation was found between AgNOR score and outcome of the disease ("vital status"), clinical stage and OS respectively. By means of discriminant analysis a threshold value of AgNOR score was identified (= 9.5) which distinguished two risk groups among the cases under examination. Those cases with an average AgNOR score below the threshold value showed a favourable prognosis. The cases with an AgNOR score greater than 9.5 had an unfavourable outcome. The authors suggest that AgNOR score may be used as a prognostic parameter in breast carcinoma.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009697 Nucleolus Organizer Region The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Nucleolar Organizer,Nucleolar Organizers,Nucleolus Organizer Regions,Organizer Region, Nucleolus,Organizer Regions, Nucleolus,Organizer, Nucleolar,Organizers, Nucleolar,Region, Nucleolus Organizer,Regions, Nucleolus Organizer
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002285 Carcinoma, Intraductal, Noninfiltrating A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma. Carcinoma, Intraductal,DCIS,Ductal Carcinoma In Situ,Atypical Ductal Hyperplasia,Intraductal Carcinoma, Noninfiltrating,Atypical Ductal Hyperplasias,Carcinoma, Noninfiltrating Intraductal,Carcinomas, Intraductal,Carcinomas, Noninfiltrating Intraductal,Ductal Hyperplasia, Atypical,Ductal Hyperplasias, Atypical,Hyperplasia, Atypical Ductal,Hyperplasias, Atypical Ductal,Intraductal Carcinoma,Intraductal Carcinomas,Intraductal Carcinomas, Noninfiltrating,Noninfiltrating Intraductal Carcinoma,Noninfiltrating Intraductal Carcinomas
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
January 1993, Oncology,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
September 1992, Ceskoslovenska patologie,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
January 1997, Auris, nasus, larynx,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
February 1995, Hepatology (Baltimore, Md.),
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
August 1994, Gynecologic oncology,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
November 2000, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
October 1991, Cancer research,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
July 1997, Journal of surgical oncology,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
November 1995, The Journal of urology,
M Canepa, and C Gambini, and L Borgiani, and A Pastorino, and G Buccaran, and L Gallo, and A Storace, and S Rovida
January 1995, Acta cytologica,
Copied contents to your clipboard!